menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Attralus

Developing transformative medicines to improve the lives of patients with systemic amyloidosis.

Autobahn Therapeutics

Develops targeted therapeutics for neurological diseases using brain-targeting chemistry platform to create regenerative treatments for CNS disorders.

Avalyn Pharma

Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.

Axial Therapeutics

Develops microbiome-based therapeutics targeting neurological disorders through gut-brain axis interventions using small molecule treatments.

Be Biopharma

Develops engineered B cell medicines and protein-based therapies to treat serious diseases, focusing on innovative therapeutic solutions.

Billiontoone-Logo

BillionToOne

Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

Biomason

Develops sustainable biocement using biotechnology and natural processes to create eco-friendly concrete alternatives that reduce carbon emissions.

Biosplice

Developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.

BostonGene

Advances personalized medicine and precision oncology by providing insights into the molecular profile of cancer.

CaaMTech

Pharmaceutical company develops novel psychedelic-inspired therapeutics targeting serotonin receptors to advance mental health treatments.

Cajal Neuroscience

Discovers drug targets for neurodegenerative diseases using advanced microscopy and genomics to develop treatments for brain disorders.

Cambrian Bio

Clinical-stage drug development company.

CAMP4

Specializes in programmable RNA-based therapeutics, which aim to provide targeted treatments for a variety of complex diseases.

Capstan Therapeutics-Logo

Capstan

In vivo engineering of cells through targeted lipid nanoparticles.

Cardurion Pharma

Clinical-stage biotech company developing innovative treatments for cardiovascular diseases through PDE9 inhibition and CaMKII targeting.

Caris Life Sciences

Develops molecular profiling technologies to assess DNA, RNA, and proteins, improving healthcare outcomes.

Carrot Fertility-Logo

Carrot Fertility

Medical services including egg freezing and in vitro fertilization (IVF).

Cellanome

Offers a platform enabling researchers to study individual cell behaviors and interactions at scale.